Cocklebur Allergy Shots (SCIT)
Cocklebur allergy shots (SCIT) address a widespread agricultural-weed aeroallergen whose spiny burs are immediately recognizable but whose real allergological work — wind-dispersed late-summer pollen — goes entirely unnoticed. Xanthium strumarium sensitizes 7–12% of fall-symptomatic Midwest and Plains patients, with higher rates documented in agricultural China, and fits squarely into the corn-and-soybean-belt fall-weed profile alongside short ragweed, giant ragweed, and marshelder.
About Curex’s SCIT program
Curex’s at-home allergy shots (SCIT) are coming soon and focus on the most common environmental allergens:
- • Pollens — tree, grass, weed & ragweed
- • Pet dander — cat & dog
- • Dust mites
- • Molds — Alternaria & mold mix
Cockleburis covered here for general education and may not be part of Curex’s current treatment set. Join the waitlist and our care team will help confirm your options.
Cocklebur Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to cocklebur — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of cocklebur allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of cocklebur immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of cocklebur extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for cocklebur allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
- Or at home with no clinic visits— Curex’s Virtual Shot Room model delivers the same SCIT program with live video supervision by trained Curex clinical staff for the first injection from each new vial or concentration and restarts after gaps or reactions.
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing cocklebur extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription cocklebur immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat cocklebur allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Cocklebur?
The biology, taxonomy, and clinical fingerprint of Cocklebur — the foundation of how SCIT targets it.
Cocklebur is recognized by farmers everywhere for its spiny burs — but the real allergy culprit is the wind-dispersed late-summer pollen produced weeks before the burs mature
- Scientific name
- Xanthium strumarium
- Family
- AsteraceaeComposite / Daisy family
- Type
- Annual weed pollen
- Native to
- North America; naturalized worldwide in disturbed agricultural ground
- Allergen proteins
- No WHO/IUIS-characterized allergens; candidate proteins Xan Ib and Xan VIa described in older immunoblot studies (Weber 2003, Ann Allergy Asthma Immunol)Profilin and polcalcin pan-allergens presumed presentTribe Heliantheae membership suggests potential cross-reactive proteins with ragweed and sunflower, but molecular data are absent
- Particle size
- N/A — uncharacterized
- Avoidance difficulty
- Very difficult
How Cocklebur Allergy Presents
Symptoms by body system — useful for distinguishing Cocklebur sensitivity from overlapping allergies and infections.
Respiratory
- Late-summer rhinitis beginning in August in corn-and-soybean-belt agricultural zones
- Nasal congestion and sneezing peaking in September across the Midwest, Great Plains, and Texas
- Allergic asthma exacerbations during cocklebur pollen peak — Heliantheae tribe member with likely airway inflammatory potential
- Post-nasal drip and throat clearing during the August–October window
- Symptoms frequently misattributed solely to ragweed when cocklebur co-sensitization extends the peak
Ocular
- Bilateral conjunctivitis and tearing during September cocklebur peak
- Periocular itching on high-count late-summer days
- Eyelid swelling in highly sensitized agricultural workers
- Symptoms overlapping with short ragweed season — difficult to distinguish without component testing
Skin
- Mechanical skin injury from spiny burs catching on skin, clothing, and animal fur — not allergic; purely physical trauma
- Potential Asteraceae sesquiterpene lactone contact dermatitis from handling plant stems (tribe Heliantheae)
- OAS from Heliantheae profilin pan-allergens theoretically possible but uncharacterized for Xanthium
- Atopic dermatitis flares during August–October pollen season
Systemic
- Fatigue and sleep disruption from prolonged uncontrolled late-summer rhinitis during harvest season
- Reduced outdoor work capacity for grain farmers during August–October harvest
- Cocklebur seedlings are highly toxic to livestock (carboxyatractyloside) — a separate veterinary concern unrelated to human pollen allergy; should not alarm patients when reading about cocklebur toxicity
- Cumulative exposure for farm workers in cocklebur-dense river bottoms and disturbed ground
Farmers know cocklebur by the burs, not the pollen — and that's exactly why we miss the diagnosis. The burs come off in October when the symptoms have already started; the pollen has been airborne since early August.
When & Where Cocklebur Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: September across the Midwest, Great Plains, and Texas; onset late August in southern latitudes· ~8–10 weeks of pollen production; monoecious annual producing pollen from male flowers atop axillary spikes
US Exposure Map
11 high-intensity statesExposure intensity by state (text version)
- ME:
- Low
- VT:
- Low
- NH:
- Low
- WA:
- Low
- MT:
- Low
- ND:
- Moderate
- MN:
- Moderate
- WI:
- Moderate
- MI:
- Moderate
- NY:
- Low
- MA:
- Low
- OR:
- Low
- ID:
- Low
- WY:
- Low
- SD:
- Moderate
- IA:
- High
- IL:
- High
- IN:
- High
- OH:
- High
- PA:
- Low
- NJ:
- Low
- CT:
- Low
- RI:
- Low
- CA:
- Low
- NV:
- Low
- UT:
- Low
- CO:
- Low
- NE:
- High
- MO:
- High
- KY:
- Moderate
- WV:
- Low
- VA:
- Low
- MD:
- Low
- DE:
- Low
- AZ:
- Low
- NM:
- Low
- KS:
- High
- AR:
- High
- TN:
- Moderate
- NC:
- Moderate
- SC:
- Moderate
- OK:
- High
- LA:
- Moderate
- MS:
- High
- AL:
- Moderate
- GA:
- Moderate
- TX:
- High
- FL:
- Low
- AK:
- Low
- HI:
- Low
What Cocklebur Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Cocklebur's tribe Heliantheae membership places it in the same botanical group as sunflower and ragweed, but published cross-reactivity data at the molecular level are essentially absent; clinical co-sensitization with ragweed and marshelder is high in Midwest populations based on extract-level testing.
Subtribe Ambrosiinae within Heliantheae — closer kinship to ragweed; frequently co-treated in Midwest fall-weed vials
Iva xanthiifolia — same subtribe Ambrosiinae; Northern Plains distribution overlaps with cocklebur habitat
Same tribe Heliantheae; both tall annuals of disturbed agricultural ground; frequently co-sensitized in Midwest farm workers
Is SCIT Right for Your Cocklebur Allergy?
Answer five questions to evaluate whether cocklebur SCIT is appropriate for your Midwest or Plains agricultural-zone fall allergy profile.
Do you work in agriculture or live adjacent to cultivated fields, river bottoms, or livestock pasture in the Midwest or Plains?
The Cocklebur SCIT Protocol
Cocklebur SCIT uses non-standardized Xanthium strumarium extract (W/V or PNU/mL labeled); no WHO/IUIS allergens have been characterized and no SCIT RCT has been published for this species. Clinical use is based on confirmed sensitization rates and regional pollen monitoring; cocklebur extract is routinely combined in Midwest agricultural-zone fall-weed vials.
Progressive dose escalation with mandatory 30-minute post-injection observation. Spring build-up (February–May) is particularly important for farm workers because the August–October harvest season conflicts directly with weekly clinic visits. The cocklebur component is typically included in a combined Midwest fall-weed vial with short ragweed, giant ragweed, marshelder, and pigweed.
Ongoing maintenance injections sustain tolerance. September symptom reduction is the primary endpoint for confirming cocklebur component effectiveness in the combined vial. Harvest-season schedule adjustments may be considered under allergist supervision; any interval change must be reviewed by your allergist — patients should never self-adjust the dosing schedule.
After successful completion, durable tolerance is expected. Agricultural workers with continuing high cocklebur exposure may benefit from extended maintenance beyond 5 years given ongoing pollen load.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Cocklebur SCIT
No published RCT evaluates SCIT specifically for Xanthium strumarium. Clinical use rests on sensitization data and extrapolation from the general weed SCIT evidence framework. The Asian literature documents higher sensitization rates (up to 18% in Chinese pollinosis cohorts, Han et al. 2018), suggesting clinically significant allergenicity that is likely under-studied in the US.
- Sensitization rate in Midwest fall-symptomatic patients10%Regional NAB / allergy clinic data — 7–12% of fall-symptomatic patients in Midwest and Plains; up to 18% in agricultural China (Han et al. 2018, Allergy Asthma Immunol Res)
- US agricultural cocklebur distribution (USDA PLANTS)48%USDA PLANTS Database — documented in all 48 contiguous states; especially dense in agricultural Midwest river systems and disturbed ground
No cocklebur-specific SCIT RCT has been published. Clinical use in Midwest fall-weed vials is supported by confirmed sensitization data and regional aerobiology; the agricultural Asian literature supports meaningful allergenicity. Patients should be clearly informed of the limited evidence base, particularly the absence of characterized allergen proteins, before starting therapy.
Ready to skip the surprise bills?
At-home allergy shots (SCIT) are designed by board-certified allergists. See the listed SCIT plan rate in our pricing record and request a quote for eligibility, initiation and total care costs.
- MD-ledBoard-certified allergists
- QuoteTotal care estimate
- 50K+Patients treated
- HSA/FSAEligible
Cocklebur SCIT Side Effects
Cocklebur SCIT follows the standard inhalant SCIT safety profile with mandatory 30-minute post-injection observation. The plant's seedling toxicity (carboxyatractyloside — a veterinary concern) is not present in pollen extract at clinical concentrations.
Local reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Injection-site swelling | Rate 30–50% | Mild |
Injection-site itching | Rate 20–40% | Mild |
Injection-site redness | Rate 20–35% | Mild |
Large local reaction (>5 cm) | Rate 5–10% | Moderate |
Systemic reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Rhinitis/conjunctivitis flare | Rate 1–3% | Mild |
Generalized urticaria | Rate 0.1–0.5% | Moderate |
Mild asthma exacerbation | Rate 0.1–0.5% | Moderate |
Anaphylaxis A prescribed epinephrine auto-injector is confirmed on hand at the injection location; 30-minute observation mandatory | Rate <0.01% per injection | Severe |
Cocklebur pollen extract SCIT has a safety profile consistent with standard inhalant immunotherapy; the plant's carboxyatractyloside (seedling livestock toxin) is absent from pollen extract formulations and is not a concern for human SCIT.
SCIT vs Alternatives for Cocklebur
Agricultural-zone patients with cocklebur sensitization typically receive a combined Midwest fall-weed vial rather than cocklebur SCIT alone; the alternative options are SLIT drops, medications, or avoidance.
| Criterion | At-Home SCIT (Curex)Best | SLIT | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Extrapolated — no cocklebur RCT | Extrapolated evidence base | Very difficult — dominant agricultural weed | Symptom suppression only |
| 5-yr cost | $3,500–$8,000 out-of-pocket | Custom sublingual drops | Low direct cost | $300–$1,200/year |
| Duration | 3–5 years | 3–5 years | Seasonal | Daily during season |
| Convenience | Self-administered weekly then monthly at home with Curex | Daily drops at home — ideal for farm workers | Not feasible for farm workers | Convenient but impairs farm alertness |
| Safety | Systemic reaction <0.01%/injection | Lower systemic risk | Complete | Well-tolerated |
| Lasting effect | Durable benefit expected | Durable benefit expected | No lasting effect | No lasting effect |
At-Home SCIT (Curex)Best
SLIT
Avoidance
Medications
Full-time farm workers who can't take a half-day off for clinic injections during August–October harvest no longer have to choose between treatment and the field. Curex delivers cocklebur immunotherapy — combined with short ragweed, giant ragweed, marshelder, and pigweed — as one weekly at-home shot with pricing confirmed in a current program quote, with a USP <797> sterile-compounded serum, allergist oversight, a prescribed epinephrine auto-injector confirmed on hand, and the first injection from each new vial or concentration supervised live in the Virtual Shot Room by trained Curex clinical staff.
What Cocklebur SCIT Actually Costs
Cocklebur SCIT as a component of a Midwest fall-weed vial is covered under standard allergy immunotherapy benefits by most major insurers when a board-certified allergist documents sensitization; coverage terms depend on plan deductible and co-insurance. Curex at-home IgE testing identifies specific cocklebur sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
See the listed Environmental Allergy Shots Plan rate, commercial terms dated 2026-10-12; consultations are included without copay. Confirm availability, eligibility, other included services, testing, any in-person care, insurance responsibility and billing cadence in your written quote before enrolling.
Join the waitlistStop guessing about your cocklebur allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Cocklebur SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
No — the spiny burs that catch on socks, dog fur, and horse manes are seeds, not flowers. They mature in October and November after the allergy-relevant event — late-summer pollen release — has already occurred. Cocklebur produces pollen from male flowers atop axillary spikes from early August through October; this lightweight, wind-dispersed pollen is the allergenic component. The burs themselves have nothing to do with respiratory allergy. This is one of the most common misconceptions about cocklebur allergy: patients often time their symptoms to when they start finding burs in their jeans, but the pollen was airborne for weeks before the burs appeared.
Cocklebur (Xanthium strumarium) sensitization affects approximately 7–12% of fall-symptomatic patients in Midwest and Great Plains allergy clinics. In agricultural China, where cocklebur is also a prevalent weed, sensitization rates in pollinosis cohorts reach 18% (Han et al. 2018, Allergy Asthma Immunol Res). This makes cocklebur a clinically meaningful regional allergen in the agricultural belt — less prevalent than short ragweed but significantly more common than many less-studied weeds. It is most relevant for farm workers, rural residents, and anyone with regular exposure to disturbed soil, river bottoms, or livestock-pastured fields in the Midwest, Great Plains, and Texas.
The most reliable way is allergen-specific IgE blood testing or skin prick testing that includes both short ragweed (Amb a 1) and Xanthium strumarium (cocklebur whole-pollen extract). Peak timing is a clinical clue: short ragweed peaks in August and September, cocklebur peaks in September. Patients who notice their worst symptoms in September rather than August, especially if they live or work near disturbed agricultural ground, are more likely to have significant cocklebur sensitization. A board-certified allergist in the Midwest or Plains region can order a regional fall-weed panel that includes both allergens, as well as giant ragweed and marshelder, to identify all contributors to the fall symptom burden.
Cocklebur seedlings contain carboxyatractyloside, a diterpenoid glycoside that is highly toxic to livestock — particularly hogs, cattle, and poultry — when seedlings are ingested during germination. This is a well-documented veterinary concern in livestock farming. However, this toxin is present in seedlings and immature plants; mature cocklebur pollen does not contain carboxyatractyloside at clinically relevant levels, and pollen extracts used for allergy testing and SCIT do not carry this toxicity risk. Human pollen allergy to cocklebur is an entirely separate IgE-mediated phenomenon unrelated to the plant's phytochemical toxicity.
SCIT can meaningfully reduce August–October symptoms over a 3–5 year course, which would improve work quality during harvest. The traditional logistical hurdle for farm workers was timing: clinic-based build-up requires weekly visits that conflict with the August–October harvest. Curex removes that conflict by delivering the same allergen immunotherapy as a weekly at-home shot — no clinic trips — with a board-certified allergist overseeing the plan, a prescribed epinephrine auto-injector confirmed on hand, and the first dose plus every escalation supervised live in the Virtual Shot Room. A large safety study of self-administered allergen immunotherapy (Schaffer et al., 2015) found that across 23,614 patients giving 2,021,600 injections the systemic reaction rate was just 0.16% per patient with no fatalities — lower than the 3%–14% typically seen with office-based shots. Building up in spring (February–May) to reach maintenance before August still maximizes first-season benefit, and once on ongoing maintenance, harvest-season intervals can be adjusted under allergist supervision.
Cocklebur SCIT as a component of a Midwest fall-weed vial is typically covered by major US insurers under standard allergy immunotherapy benefits when ordered by a board-certified allergist with documented sensitization through skin prick or specific IgE testing. CPT codes for injection administration (95115, 95117) and extract preparation (95165) apply. The non-standardized nature of cocklebur extract does not typically affect coverage decisions. Plan deductible and co-insurance structure determines out-of-pocket costs; prior authorization may be required and should be confirmed before starting the build-up series.
A comprehensive fall-weed panel for a Midwest or Plains patient with suspected cocklebur sensitization should include: short ragweed (Amb a 1 for confirmed ragweed sensitization), giant ragweed (Amb t 5), western ragweed (Amb p 5) for Plains patients, marshelder / rough marshelder (Iva annua / Iva xanthiifolia, ImmunoCAP w16), and pigweed (Amaranthus retroflexus). In Texas, lamb's quarters (Chenopodium album) and kochia (Bassia scoparia) are often added. Cocklebur commonly co-occurs with giant ragweed in Midwest river-bottom environments, making both a standard part of the agricultural-zone fall-weed differential.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Questions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.